NCT04388813View on ClinicalTrials.gov

Predictors of Severe COVID-19 Outcomes

CompletedOBSERVATIONAL
Enrollment

494

Participants

Timeline

Start Date

May 28, 2020

Primary Completion Date

September 23, 2021

Study Completion Date

September 23, 2021

Conditions
Acute Respiratory Distress SyndromeCOVID-19
Trial Locations (8)

10065

Weill Cornell Medical College, New York

22042

Inova Health Care Services, Falls Church

60607

University of Illinois at Chicago, Chicago

60612

Rush University Medical Center, Chicago

75390

University of Texas Southwestern Medical Center, Dallas

77030

Baylor College of Medicine, Houston

85719

The University of Arizona, Tucson

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Verily Life Sciences LLC

INDUSTRY

NCT04388813 - Predictors of Severe COVID-19 Outcomes | Biotech Hunter | Biotech Hunter